STOCK TITAN

Neurometrix Stock Price, News & Analysis

NURO NASDAQ

Company Description

About NeuroMetrix Inc (NURO)

NeuroMetrix Inc is a commercial-stage healthcare company that excels in the development and commercialization of innovative bioelectrical and digital medicine solutions. With a firm focus on addressing chronic health conditions such as chronic pain, sleep disturbances, and diabetes, the company integrates advanced neurotechnology into its product offerings, including wearable neuromodulation devices and point-of-care diagnostic tests. From its origins as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996, NeuroMetrix has continuously maintained active research programs and an innovation-driven pipeline, dedicating its expertise to provide drug-free therapeutic alternatives and diagnostic solutions.

Core Business and Product Excellence

At its core, NeuroMetrix combines in-house capabilities in product design, manufacturing, regulatory compliance, sales, and customer support to deliver products that cater to critical healthcare needs. The company\s product portfolio comprises wearable neuromodulation technologies—designed for managing chronic pain conditions such as back pain, arthritic pain, and neuropathy—and specialized point-of-care tests that assist in early screening for diabetic peripheral neuropathy. By blending clinical neurostimulation with digital tools, such as integrated mobile apps and cloud-based systems, NeuroMetrix offers a holistic approach that supports both patients and healthcare providers.

Market Position and Industry Significance

Operating within the highly specialized medical equipment sector, NeuroMetrix has strategically positioned itself as a company that not only innovates but also rigorously validates its clinical solutions. Its use of advanced bioelectrical techniques places it among those offering drug-free therapeutic alternatives, an aspect that resonates with both healthcare professionals and patients seeking safer treatment modalities. The company\s commitment to research and development is evidenced by its robust pipeline and multiple patent protections covering its neuromodulation and diagnostic technologies. These attributes underscore its expertise in cellular and nervous system dynamics, essential for thriving within a competitive and technically demanding market.

Operational Excellence and Integrated Capabilities

NeuroMetrix\s operational model is marked by its end-to-end integration. It manages every stage from early research and product development to manufacturing, regulatory compliance, and post-market customer support. This comprehensive approach enables the company to optimize product design, ensure rapid iterations in response to clinical feedback, and support healthcare providers in utilizing its technologies effectively. The seamless integration of hardware with associated digital applications further enhances its clinical utility by allowing for real-time monitoring and data-driven decision-making in chronic care management.

Addressing Unmet Clinical Needs

One of the hallmarks of NeuroMetrix is its unwavering focus on providing effective solutions for conditions often deemed difficult to manage. By prioritizing research and innovation, the company has developed therapeutic devices that serve as non-invasive, drug-free options for patients burdened by chronic health issues. Its endeavors in neuromodulation and diagnostic screening not only bring forward a new dimension to medical care but also provide doctors with the necessary tools to better manage and mitigate long-term pain and related complications. This dual focus reinforces the company\s role as a catalyst for change in the modern medical landscape.

Expertise and Reliability in a Competitive Landscape

Despite challenges that every innovator faces, including evolving regulatory requirements and competitive pressures from both traditional treatment options and emerging technologies, NeuroMetrix continues to stand out due to its detailed attention to clinical validation and active R&D investments. The company\s integration of hardware innovation, digital health applications, and rigorous clinical data analysis positions it as a trusted source for device-driven therapeutic solutions. Its commitment to patient outcomes and evidence-based practices further bolsters its reputation among clinicians and investors alike.

Commitment to Continuous Innovation and Quality

  • Advanced Neuromodulation: Utilizing cutting-edge bioelectrical techniques to modulate nerve signals and provide non-invasive pain relief.
  • Digital Integration: Seamlessly integrating therapies with digital platforms for enhanced user experience and clinical tracking.
  • Focused Diagnostics: Innovating point-of-care diagnostic tests to detect and monitor diabetic peripheral neuropathy effectively.
  • Holistic Healthcare: A comprehensive approach that interlinks clinical research, product development, and direct healthcare application.

The highly specialized technology and systematic approach adopted by NeuroMetrix underscore its commitment to innovation and quality. Every product is designed with the end user in mind, ensuring that both patients and healthcare professionals benefit from reliable, effective, and user-friendly solutions. This synergy between advanced technology and clinical precision is the foundation upon which NeuroMetrix has built its market presence and continues to evolve within the complex ecosystem of digital medicine and chronic care management.

Stock Performance

$—
0.00%
0.00
Last updated:
15.32 %
Performance 1 year
$8.9M
Market Cap
2.1M
Shares outstanding

SEC Filings

No SEC filings available for Neurometrix.

Financial Highlights

$587,314
Revenue (TTM)
-$1,508,226
Net Income (TTM)
-$0.75
Diluted EPS (TTM)
-$1,792,448
Operating Cash Flow
-256.80%
Net Profit Margin
-296.61%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Neurometrix (NURO)?

The current stock price of Neurometrix (NURO) is $4.375 as of April 24, 2025.

What is the market cap of Neurometrix (NURO)?

The market cap of Neurometrix (NURO) is approximately 8.9M.

What is the revenue (TTM) of Neurometrix (NURO) stock?

The trailing twelve months (TTM) revenue of Neurometrix (NURO) is $587,314.

What is the net income of Neurometrix (NURO)?

The trailing twelve months (TTM) net income of Neurometrix (NURO) is -$1,508,226.

What is the earnings per share (EPS) of Neurometrix (NURO)?

The diluted earnings per share (EPS) of Neurometrix (NURO) is -$0.75 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Neurometrix (NURO)?

The operating cash flow of Neurometrix (NURO) is -$1,792,448.

What is the profit margin of Neurometrix (NURO)?

The net profit margin of Neurometrix (NURO) is -256.80%.

What is the operating margin of Neurometrix (NURO)?

The operating profit margin of Neurometrix (NURO) is -296.61%.

What is the gross margin of Neurometrix (NURO)?

The gross profit margin of Neurometrix (NURO) is 53.12%.

What is the current ratio of Neurometrix (NURO)?

The current ratio of Neurometrix (NURO) is 13.88, indicating the company's ability to pay short-term obligations.

What is the gross profit of Neurometrix (NURO)?

The gross profit of Neurometrix (NURO) is $311,957 on a trailing twelve months (TTM) basis.

What is the operating income of Neurometrix (NURO)?

The operating income of Neurometrix (NURO) is -$1,742,048.

What does NeuroMetrix Inc specialize in?

NeuroMetrix focuses on developing and commercializing innovative bioelectrical and digital medicine devices aimed at managing chronic pain, sleep disorders, and diabetic complications.

What kinds of products does NeuroMetrix offer?

The company offers wearable neuromodulation devices for chronic pain management and point-of-care diagnostic tests for early screening of conditions such as diabetic peripheral neuropathy.

How does NeuroMetrix integrate technology into its solutions?

NeuroMetrix integrates state-of-the-art bioelectrical stimulation with digital platforms such as mobile apps and cloud-based systems, ensuring both real-time monitoring and optimized patient care.

What is the primary market segment for NeuroMetrix?

The company operates primarily within the medical equipment sector, targeting patients and healthcare providers seeking innovative, non-invasive treatment options.

What sets NeuroMetrix apart from other medical device companies?

Its comprehensive in-house capabilities—from research and product development to manufacturing and customer support—combined with a robust focus on digital integration, distinguish it from competitors.

How does NeuroMetrix support healthcare providers?

The company provides clinically validated devices that are supported by user-friendly digital applications, ensuring healthcare providers can effectively implement these solutions in their practices.

What are the technological highlights of its products?

NeuroMetrix products leverage advanced neuromodulation techniques, integrated sensors, and proprietary software solutions, which together offer precision and efficiency in both therapeutic and diagnostic applications.

Can you explain NeuroMetrix's approach to improving patient outcomes?

By combining bioelectrical stimulation with digital health innovations, NeuroMetrix offers drug-free, non-invasive therapeutic options that are clinically validated, improving the management of chronic conditions.